BAYER AKTIENGESELLSCHAFT
- Country
- Germany
- Type
- Beneficiary
- Website
- www.bayerpharma.de
- Grants received
- 75
Funding record
- 75 grants on record
- €4,898,800.01 awarded in total
- 2015–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
56 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- JANSSEN PHARMACEUTICA NV
- ASTRAZENECA AB
- NOVARTIS PHARMA AG
- ABBVIE INC
- ELI LILLY AND COMPANY LTD
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
- MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
Calls from this organisation
No published calls from this organisation.
Grants received
- Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases
- Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)
- Beyond neuroInflammation: new Concepts to Elucidate the immune system’s vital role in Parkinson’s disease
- Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models
- Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- Light-driven Catalytic Processes for the Stereoselective Functionalisation of C(sp3)-H Bonds
- Sharing and re-using clinical trial data to maximise impact
- Food Safety for Africa
- INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE
- Explainable AI for Molecules - AiChemist
- a research and InNOvation Partnership for enhancing the surveillance and control of mosquito VECtors of emerging arboviruses
- Advanced biodiversity monitoring for results-based and effective agricultural policy and transformation
- Risk AssessmenT InnOvatioN for low-risk pesticides
- Photochemical organocatalytic atropselective processes for the sustainable synthesis of biorelevant axially chiral molecules
- Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.